Literature DB >> 16652060

Mortality in HIV-infected and uninfected children of HIV-infected and uninfected mothers in rural Uganda.

Heena Brahmbhatt1, Godfrey Kigozi, Fred Wabwire-Mangen, David Serwadda, Tom Lutalo, Fred Nalugoda, Nelson Sewankambo, Mohamed Kiduggavu, Maria Wawer, Ronald Gray.   

Abstract

OBJECTIVE: To estimate 2-year mortality rates in HIV-1-infected and uninfected infants born to HIV and HIV mothers.
METHODS: Data are from a prospective study in rural Rakai District, Uganda. Infant HIV status (determined by polymerase chain reaction) was evaluated at 1 to 6 weeks postpartum and during breast-feeding, and maternal HIV viral load and CD4 levels were measured at the postpartum visit. Multivariate Cox proportional hazards models and Kaplan-Meier survival analysis were used to assess survival of infants by maternal and infant HIV status and by quartiles of viral load. Log-rank tests were used to test the equality of survival functions.
RESULTS: Of the 4604 pregnant women, 16.9% were HIV, and the proportion of children infected was 20.9%. Median survival of HIV-infected infants was 23 months. Two-year child mortality rates were 128 of 1000 children born to HIV mothers, 165.5 of 1000 uninfected children born to HIV mothers, and 540.1 of 1000 HIV-infected children (P < 0.0001). Compared with children of HIV mothers, the hazard of child mortality was 2.04 (P < 0.001) if the mother was HIV and 3.78 (P < 0.001) if the infant was also infected. In the adjusted model, the highest quartiles of log10 HIV viral load in infants and mothers were associated with significantly increased hazard of child mortality (hazard ratio [HR] = 8.54 and HR = 2.50, respectively). Maternal CD4 counts <200 cells/mL were also significant predictors of child mortality (HR = 2.61). A total of 67.6% of HIV-infected children with viral loads above the median died by the age of 2 years and are in need of early antiretroviral therapy (ART).
CONCLUSIONS: More than half of HIV-infected infants died at less than 2 years of age. Therefore, ART may need to be initiated earlier in HIV-infected African children.

Entities:  

Mesh:

Year:  2006        PMID: 16652060     DOI: 10.1097/01.qai.0000188122.15493.0a

Source DB:  PubMed          Journal:  J Acquir Immune Defic Syndr        ISSN: 1525-4135            Impact factor:   3.731


  95 in total

1.  More on the cohort-component model of population projection in the context of HIV/AIDS: A Leslie matrix representation and new estimates.

Authors:  Jason R Thomas; Samuel J Clark
Journal:  Demogr Res       Date:  2011-07-05

2.  Analysis of HIV tropism in Ugandan infants.

Authors:  Jessica D Church; Wei Huang; Anthony Mwatha; Philippa Musoke; J Brooks Jackson; Danstan Bagenda; Saad B Omer; Deborah Donnell; Clemensia Nakabiito; Chineta Eure; Laura A Guay; Allan Taylor; Paul M Bakaki; Flavia Matovu; Michelle McConnell; Mary Glenn Fowler; Susan H Eshleman
Journal:  Curr HIV Res       Date:  2010-10       Impact factor: 1.581

3.  Can Disease-Specific Funding Harm Health? in the Shadow of HIV/AIDS Service Expansion.

Authors:  Nicholas Wilson
Journal:  Demography       Date:  2015-10

4.  Short communication: CD8(+) T cell polyfunctionality profiles in progressive and nonprogressive pediatric HIV type 1 infection.

Authors:  Christina F Thobakgale; Hendrik Streeck; Nompumelelo Mkhwanazi; Zenele Mncube; Lungile Maphumulo; Fundisiwe Chonco; Andrew Prendergast; Gareth Tudor-Williams; Bruce D Walker; Philip J R Goulder; Marcus Altfeld; Thumbi Ndung'u
Journal:  AIDS Res Hum Retroviruses       Date:  2011-03-21       Impact factor: 2.205

Review 5.  HIV-exposed uninfected children: a growing population with a vulnerable immune system?

Authors:  L Afran; M Garcia Knight; E Nduati; B C Urban; R S Heyderman; S L Rowland-Jones
Journal:  Clin Exp Immunol       Date:  2014-04       Impact factor: 4.330

6.  Mother-to-child transmission of HIV: a global perspective.

Authors:  Katherine Luzuriaga
Journal:  Curr Infect Dis Rep       Date:  2007-11       Impact factor: 3.725

7.  Efficacy and safety of three regimens for the prevention of malaria in young HIV-exposed Ugandan children: a randomized controlled trial.

Authors:  Moses R Kamya; James Kapisi; Victor Bigira; Tamara D Clark; Stephen Kinara; Florence Mwangwa; Mary K Muhindo; Abel Kakuru; Francesca T Aweeka; Liusheng Huang; Prasanna Jagannathan; Jane Achan; Diane V Havlir; Philip J Rosenthal; Grant Dorsey
Journal:  AIDS       Date:  2014-11-28       Impact factor: 4.177

8.  Pregnancy Outcomes in the Era of Universal Antiretroviral Treatment in Sub-Saharan Africa (POISE Study).

Authors:  Sufia Dadabhai; Luis Gadama; Rachel Chamanga; Rachel Kawalazira; Chaplain Katumbi; Bonus Makanani; Dingase Dula; Nan Hua; Bryan Lau; Macpherson Mallewa; Taha E Taha
Journal:  J Acquir Immune Defic Syndr       Date:  2019-01-01       Impact factor: 3.731

9.  Early HIV-1 diagnosis using in-house real-time PCR amplification on dried blood spots for infants in remote and resource-limited settings.

Authors:  Nicole Ngo-Giang-Huong; Woottichai Khamduang; Baptiste Leurent; Intira Collins; Issaren Nantasen; Pranee Leechanachai; Wasna Sirirungsi; Aram Limtrakul; Tasana Leusaree; Anne Marie Comeau; Marc Lallemant; Gonzague Jourdain
Journal:  J Acquir Immune Defic Syndr       Date:  2008-12-15       Impact factor: 3.731

10.  Determining an optimal testing strategy for infants at risk for mother-to-child transmission of HIV-1 during the late postnatal period.

Authors:  Elizabeth Brown; Benjamin H Chi; Jennifer S Read; Taha E Taha; Usha Sharma; Irving F Hoffman; Cheryl Pikora; Robert Goldenberg; Susan A Fiscus
Journal:  AIDS       Date:  2008-11-12       Impact factor: 4.177

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.